Do you routinely include sipuleucel-T as one of your lines of systemic therapy for metastatic castration resistant prostate cancer?   

If so, how do you sequence this with other therapies?  In addition, in the absence of an effect on radiographic PFS or serum PSA, how do you assess when to start the next therapy after vaccine administration?

Answer from: Medical Oncologist at Academic Institution